Literature DB >> 80159

Type C oncornavirus isolation studies in systemic lupus erythematosus. II. Attempted detection by viral RNA-dependent DNA polymerase assay.

P E Phillips, R Hargrave-Granda.   

Abstract

Isolation of type C oncornavirus was attempted from 20 tissues and cell cultures of patients with systemic lupus erythematosus. Chemical inducers, cocultivation and fusion with cells from multiple other species, prolonged subculturing, and the RNA-dependent DNA polymerase assay for virus detection were used. A type C virus was isolated, but was shown to be the endogenous rat virus. Thus the methods, although generally appropriate, were not specifically permissive for replication of a human type C virus. This agrees with the failure of other investigators to isolate a virus of undisputed human origin. Combining available evidence, a fundamental role for type C viruses in lupus erythematosus remains an attractive hypothesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 80159      PMCID: PMC1000211          DOI: 10.1136/ard.37.3.225

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

1.  Endogenous C-type viral expression in primates.

Authors:  J R Stephenson; S A Aaronson
Journal:  Nature       Date:  1977-03-31       Impact factor: 49.962

2.  Type C viruses and systemic lupus erythematosus.

Authors:  J A Markenson; P E Phillips
Journal:  Arthritis Rheum       Date:  1978-03

3.  Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus.

Authors:  R C Mellors; J W Mellors
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

Review 4.  Evolution and modes of transmission of RNA tumor viruses. Parke-Davis Award lecture.

Authors:  G J Todaro
Journal:  Am J Pathol       Date:  1975-12       Impact factor: 4.307

5.  The occurrence and frequency of type C virus-like particles in placentas from patients with systemic lupus erythematosus and from normal subjects.

Authors:  M Imamura; P E Phillips; R C Mellors
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

6.  Murine xenotropic type C viruses I. Distribution and further characterization of the virus in NZB mice.

Authors:  J A Levy; P Kazan; O Varnier; H Kleiman
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

7.  Search for antigens and antibodies crossreactive with type C viruses of the woolly monkeys and gibbon ape in animal models and in humans.

Authors:  J R Stephenson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

8.  Proviral sequences of baboon endogenous type C RNA virus in DNA of human leukaemic tissues.

Authors:  F Wong-Staal; D Gillespie; R C Gallo
Journal:  Nature       Date:  1976-07-15       Impact factor: 49.962

9.  C-type virus expression in systemic lupus erythematosus.

Authors:  S Panem; N G Ordóñez; W H Kirstein; A I Katz; B H Spargo
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

10.  Molecular pathogenesis of systemic lupus erythematosus.

Authors:  Z S Alekberova; M I Parfanovich; V A Nasonova; V M Zhdanov
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

View more
  3 in total

Review 1.  Autoimmune diseases: immunopathology and etiopathogenesis.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

2.  Type C oncornavirus isolation studies in systemic lupus erythematosus. III. Isolation of a putative retravirus by triple cell fusion.

Authors:  P E Phillips; S A Sellers; S L Cotronei
Journal:  Ann Rheum Dis       Date:  1978-06       Impact factor: 19.103

3.  Viruses and lymphocytes in rheumatoid arthritis. II. Examination of lymphocytes and sera from patients with rheumatoid arthritis for evidence of retrovirus infection.

Authors:  H Hart; J N McCormick; B P Marmion
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.